Case report: Epidermolysis bullosa acquisita following dipeptidyl peptidase-4 inhibitor therapy and complicated by immune thrombocytopenic purpura. [PDF]
Front ImmunolKawamoto H +4 more
europepmc +1 more source
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives. [PDF]
Curr Opin HematolPan L, Zhu J.
europepmc +1 more source
What We Miss in Patients With Persistent Thrombocytopenia During the Dengue Season. [PDF]
CureusBisht A, Joshi R, Sama S, Rawat A.
europepmc +1 more source
[Clinical characteristics and prognosis of primary immune thrombocytopenia complicated with diffuse alveolar hemorrhage]. [PDF]
Zhonghua Xue Ye Xue Za ZhiAn ZY +8 more
europepmc +1 more source
Platelet Recovery and Coexisting Conditions in Pediatric Immune Thrombocytopenia: Insights from a Tertiary Care Study. [PDF]
Children (Basel)Singer CE +12 more
europepmc +1 more source
An Umbrella Review of Meta-Analyses on the Efficacy and Safety of Eltrombopag in Immune Thrombocytopenia. [PDF]
Health Sci RepDabir M +6 more
europepmc +1 more source
A design for an efficient functional panel that determines platelet exhaustion levels to differentiate responder and non-responder ITP patients. [PDF]
Sci RepHeidari N +6 more
europepmc +1 more source
Four-year complete remission with reduced-dose PARP inhibitor in advanced-stage epithelial ovarian cancer harboring a BRCA1 mutation: a case report of a chemotherapy-intolerant patient with idiopathic thrombocytopenic purpura. [PDF]
J Ovarian ResLu P +5 more
europepmc +1 more source